The German etanercept registry for treatment of juvenile idiopathic arthritis
G Horneff, H Schmeling, T Biedermann… - Annals of the …, 2004 - ard.bmj.com
Objective: To describe a registry set up to monitor children treated with etanercept in
Germany and Austria. Methods: Giannini's criteria, duration of morning stiffness, number of …
Germany and Austria. Methods: Giannini's criteria, duration of morning stiffness, number of …
2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American …
Objective To develop criteria for the classification of macrophage activation syndrome (MAS)
in patients with systemic juvenile idiopathic arthritis (JIA). Methods A multistep process …
in patients with systemic juvenile idiopathic arthritis (JIA). Methods A multistep process …
[HTML][HTML] Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis
Background Interleukin-1 is pivotal in the pathogenesis of systemic juvenile idiopathic
arthritis (JIA). We assessed the efficacy and safety of canakinumab, a selective, fully human …
arthritis (JIA). We assessed the efficacy and safety of canakinumab, a selective, fully human …
[HTML][HTML] Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Background Tumor necrosis factor (TNF) has a pathogenic role in juvenile rheumatoid
arthritis. We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti …
arthritis. We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti …
Update on biologicals for treatment of juvenile idiopathic arthritis
G Horneff - Expert Opinion on Biological Therapy, 2013 - Taylor & Francis
Introduction: The development of biologics has markedly changed the treatment of JIA.
Complete control of the disease and remission has today become the main goal of treatment …
Complete control of the disease and remission has today become the main goal of treatment …
[HTML][HTML] Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND …
S Hansmann, E Lainka, G Horneff, D Holzinger… - Pediatric …, 2020 - Springer
Abstract Background Rare autoinflammatory diseases (AIDs) including Cryopyrin-
Associated Periodic Syndrome (CAPS), Tumor Necrosis Receptor-Associated Periodic …
Associated Periodic Syndrome (CAPS), Tumor Necrosis Receptor-Associated Periodic …
Localized scleroderma in childhood is not just a skin disease
F Zulian, C Vallongo, P Woo, R Russo… - Arthritis & …, 2005 - Wiley Online Library
Objective Juvenile localized scleroderma is usually considered a disease that is confined to
the skin and subcutaneous tissue. We studied the prevalence and clinical features of …
the skin and subcutaneous tissue. We studied the prevalence and clinical features of …
[HTML][HTML] Leflunomide or methotrexate for juvenile rheumatoid arthritis
E Silverman, R Mouy, L Spiegel, LK Jung… - New England journal …, 2005 - Mass Medical Soc
Background We compared the safety and efficacy of leflunomide with that of methotrexate in
the treatment of polyarticular juvenile rheumatoid arthritis in a multinational, randomized …
the treatment of polyarticular juvenile rheumatoid arthritis in a multinational, randomized …
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
HI Brunner, N Ruperto, Z Zuber, C Keane… - Annals of the …, 2015 - ard.bmj.com
Objective To evaluate the interleukin-6 receptor inhibitor tocilizumab for the treatment of
patients with polyarticular-course juvenile idiopathic arthritis (pcJIA). Methods This three …
patients with polyarticular-course juvenile idiopathic arthritis (pcJIA). Methods This three …
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an
achievable goal for most patients. Reaching this target leads to improved outcomes. The …
achievable goal for most patients. Reaching this target leads to improved outcomes. The …